XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
XORTX Therapeutics Inc. reported a decrease in total assets to $3.85 million as of September 30, 2024, compared to $5.47 million at the end of 2023, alongside an increased derivative warrant liability. The company’s current liabilities rose significantly, highlighting financial challenges amid ongoing research and development expenses.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.